Form 4 for DBVT DBV Technologies S.A.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-11-22 · accession 0001209191-23-059182 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | 2023-11-22 | DBVT | Mohideen Pharis | Chief Medical Off | S - Sale | $1.74 | -2,245 | 82.2K | -3% | -$3,906 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-11-22 | S | D | 2,245 | $1.74 | 82,194 | D | — | — | (F2) This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0941 to EURO 1.00 as of November 22, 2023. (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.79 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |